Related Experiment Video
Updated: Jun 5, 2026

Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae
Published on: April 18, 2016
Calsenilin is degraded by the ubiquitin-proteasome pathway
Changhwan Jang1, Jin-Kyu Choi, EunYoung Kim
1Ilsong Institute of Life Science, Hallym University, Anyang, Republic of Korea.
Abstract:
Calsenilin, a neuronal calcium binding protein that has been shown to have multiple functions in the cell, interacts with presenilin 1 (PS1) and presenilin 2 (PS2), represses gene transcription and binds to A-type voltage-gated potassium channels. In addition, increased levels of calsenilin are observed in the brains of Alzheimer's disease and epilepsy patients. The present study was designed to investigate the molecular mechanism of calsenilin degradation pathways in cultured cells. Here, we demonstrate that inhibition of the ubiquitin-proteasomal pathway (UPP) but not lysosomal pathway markedly increased the expression levels of calsenilin. Immunofluorescence analysis revealed that following proteasomal inhibition calsenilin accumulated in the endoplasmic reticulum (ER) and Golgi, while lysosomal inhibition had no effect on calsenilin localization. In addition, we found the change of subcellular localization of PS1 from diffuse pattern to punctuate staining pattern in the ER and perinuclear region in the presence of calsenilin. These findings suggest that calsenilin degradation is primarily mediated by the UPP and that impairment in the UPP may contribute to the involvement of calsenilin in disease-associated neurodegeneration.
Insights
Calsenilin degradation primarily occurs via the ubiquitin-proteasomal pathway (UPP). Impaired UPP function may link calsenilin to neurodegenerative diseases like Alzheimer's.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Calsenilin, a neuronal calcium-binding protein, interacts with presenilins and is implicated in Alzheimer's disease and epilepsy.
- Its precise degradation pathways and role in neurodegeneration are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms governing calsenilin degradation in cultured cells.
- To determine whether the ubiquitin-proteasomal pathway (UPP) or lysosomal pathway is the primary route for calsenilin degradation.
Main Methods:
- Cell culture experiments with specific inhibitors for the UPP and lysosomal pathways.
- Immunofluorescence microscopy to analyze calsenilin and presenilin 1 (PS1) localization.
- Western blotting to assess protein expression levels.
Main Results:
- Inhibition of the UPP, but not the lysosomal pathway, significantly increased calsenilin expression levels.
- Proteasomal inhibition led to calsenilin accumulation in the endoplasmic reticulum (ER) and Golgi.
- Calsenilin presence altered PS1 localization within the ER and perinuclear regions.
Conclusions:
- Calsenilin degradation is predominantly mediated by the UPP.
- Dysfunction of the UPP may contribute to the accumulation of calsenilin in neurodegenerative conditions.
- Altered calsenilin levels and localization, potentially due to UPP impairment, could play a role in Alzheimer's disease pathogenesis.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
GPCR Desensitization

